[Federal Register Volume 61, Number 247 (Monday, December 23, 1996)]
[Notices]
[Page 67567]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-32418]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Heart, Lung, and Blood Institute Special Emphasis Panel (SEP) 
meetings:

    Name of SEP: PEACE II--Homocysteine.
    Date: January 13-14, 1997.
    Time: 7:30 p.m.
    Place: Holiday Inn Gaithersburg, 2 Montgomery Village Avenue, 
Gaithersburg, Maryland 20879.
    Contact Person: Anthony M. Coelho, Jr., Ph.D., Two Rockledge 
Center, Room 7194, 6701 Rockledge Drive, Bethesda, MD 20892-7924, 
(301) 435-0288.
    Purpose/Agenda: To review and evaluate grant applications.
    This notice is being published less than fifteen days prior to 
the meeting due to the urgent need to meet timing limitations 
imposed by the review and funding cycle.

    Name of SEP: Bogalusa Heart Study.
    Date: February 10, 1997.
    Time: 9:00 a.m.
    Place: Sheraton Crystal City Hotel, 1800 Jefferson Davis 
Highway, Arlington, Virginia.
    Contact Person: C. James Scheirer, Ph.D., Two Rockledge Center, 
Room 7220, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-
0288.
    Purpose/Agenda: To review and evaluate grant applications.

    Name of SEP: Review of the Independent Scientist Awards (K02s) 
and the Mentored Clinical Scientist Development Awards (K08s).
    Date: February 11, 1997.
    Time: 8:00 a.m.
    Place: Woodfin Suite Hotel, 1380 Piccard Drive, Rockville, 
Maryland 20852.
    Contact Person: S. Charles Selden, Ph.D., Two Rockledge Center, 
Room 7196, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-
0288.
    Purpose/Agenda: To review and evaluate grant applications.
    These meetings will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health)

    Dated: December 17, 1996.
Paula N. Hayes,
Acting Committee Management Officer, NIH.
[FR Doc. 96-32418 Filed 12-20-96; 8:45 am]
BILLING CODE 4140-01-M